These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 9471019

  • 1. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
    Smythe A, Bird NC, Troy GP, Globe J, Johnson AG.
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
    [Abstract] [Full Text] [Related]

  • 2. Proton pump inhibitor influence on reflux in Barrett's oesophagus.
    Smythe A, Troy GP, Ackroyd R, Bird NC.
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):881-7. PubMed ID: 18794602
    [Abstract] [Full Text] [Related]

  • 3. Does the addition of a prokinetic to proton pump inhibitor therapy help reduce duodenogastro-oesophageal reflux in patients with Barrett's oesophagus?
    Smythe A, Bird NC, Troy GP, Ackroyd R, Johnson AG.
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):305-12. PubMed ID: 12610326
    [Abstract] [Full Text] [Related]

  • 4. Measuring duodenogastro-oesophageal reflux (DGOR).
    de Caestecker JS.
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1141-3. PubMed ID: 9471017
    [Abstract] [Full Text] [Related]

  • 5. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
    Koek GH, Sifrim D, Lerut T, Janssens J, Tack J.
    Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
    [Abstract] [Full Text] [Related]

  • 6. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB, Boparai V, Ullah N, Triadafilopoulos G.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):637-43. PubMed ID: 15352912
    [Abstract] [Full Text] [Related]

  • 7. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R.
    Aliment Pharmacol Ther; 2006 Jan 15; 23(2):321-9. PubMed ID: 16393313
    [Abstract] [Full Text] [Related]

  • 8. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M, Manno M, De Micheli E, Savarino V.
    Dig Liver Dis; 2006 Sep 15; 38(9):643-8. PubMed ID: 16627016
    [Abstract] [Full Text] [Related]

  • 9. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
    Todd JA, Basu KK, de Caestecker JS.
    Aliment Pharmacol Ther; 2005 Apr 15; 21(8):969-75. PubMed ID: 15813832
    [Abstract] [Full Text] [Related]

  • 10. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus.
    Marshall RE, Anggiansah A, Manifold DK, Owen WA, Owen WJ.
    Gut; 1998 Nov 15; 43(5):603-6. PubMed ID: 9824338
    [Abstract] [Full Text] [Related]

  • 11. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
    Ortiz A, Martínez de Haro LF, Parrilla P, Molina J, Bermejo J, Munitiz V.
    Br J Surg; 1999 Nov 15; 86(11):1472-4. PubMed ID: 10583299
    [Abstract] [Full Text] [Related]

  • 12. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C, Going J, Neilson L, Mackay C, Stuart RC.
    Histopathology; 2005 Sep 15; 47(3):268-75. PubMed ID: 16115227
    [Abstract] [Full Text] [Related]

  • 13. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA, Anderson M.
    Aliment Pharmacol Ther; 2004 Oct 15; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [Abstract] [Full Text] [Related]

  • 14. Bile reflux in columnar-lined Barrett's oesophagus.
    Iftikhar SY, Ledingham S, Steele RJ, Evans DF, Lendrum K, Atkinson M, Hardcastle JD.
    Ann R Coll Surg Engl; 1993 Nov 15; 75(6):411-6. PubMed ID: 8285543
    [Abstract] [Full Text] [Related]

  • 15. Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia.
    Dresner SM, Griffin SM, Wayman J, Bennett MK, Hayes N, Raimes SA.
    Br J Surg; 2003 Sep 15; 90(9):1120-8. PubMed ID: 12945080
    [Abstract] [Full Text] [Related]

  • 16. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
    Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, Farahmand BY, Winchester CC, Roda E, Bazzoli F.
    Gut; 2008 Oct 15; 57(10):1354-9. PubMed ID: 18424568
    [Abstract] [Full Text] [Related]

  • 17. Barrett's oesophagus: a clinical study of 52 patients.
    Cooper BT, Barbezat GO.
    Q J Med; 1987 Feb 15; 62(238):97-108. PubMed ID: 3498962
    [Abstract] [Full Text] [Related]

  • 18. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
    Ortiz Escandell A, Martínez de Haro LF, Parrilla Paricio P, Molina Martínez J, Aguayo Albasini JL, Martínez Gómez D.
    Rev Esp Enferm Dig; 1990 Mar 15; 77(3):171-5. PubMed ID: 2378753
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.